The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis
Abstract
PURPOSE OF REVIEW: Chemotherapy against onchocerciasis and lymphatic filariasis has been discussed mainly within the framework of mass drug administration with diethylcarbamazine, ivermectin and albendazole. Although strong reductions in infection prevalence were achieved, the regimes for these drugs do not fully cover needs of individual patients who seek treatment because of symptoms. Chemotherapy against filarial Wolbachia endosymbionts with doxycycline showed higher antiparasitic efficacy in onchocerciasis and lymphatic filariasis and also improved disease. This review details the recent indications for this new treatment, focussing on regimes for individual drug administration. RECENT FINDINGS: A regimen of 6-week/100 mg doxycycline per day sterilized adult female Onchocerca volvulus. Two hundred milligrams doxycycline per day for 4 or 6 weeks revealed 50 and 60% macrofilaricidal effects, respectively. Reduction of 80-90% of adult worms was observed in bancroftian filariasis with 200 mg/day doxycycline for 4 or 6 weeks. The latter regimen showed reduction of lymph vessel dilation and of hydrocele. Lymphoedema progression was halted and reversed in early stages. SUMMARY: Different options for antiwolbachial individual drug administration are summarized here. With improving health systems in endemic countries, individuals will demand best-possible treatment and accelerate a shift from mass drug administration-only approaches to integrated approaches combining both mass drug administration and individual drug administration. Treatment may be further improved by new antibiotics detected in high-throughput settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bandi, C., McCall, J. W., Genchi, C., Corona, S., Venco, L., & Sacchi, L. (1999) · International Journal for Parasitology · doi:10.1016/s0020-7519(98)00200-8 · Cited by 250
Cited by
Human and animal dirofilariasis: The emergence of a zoonotic mosaic
Simón, F., Siles-Lucas, M., Morchón, R., González-Miguel, J., Mellado, I., Carretón, E., & Montoya-Alonso, J. A. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00012-12 · Cited by 834
Lymphatic filariasis and onchocerciasis
Taylor, M. J., Hoerauf, A., & Bockarie, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60586-7 · Cited by 686
Self-citationTolle, M. A. (2009) · Current Problems in Pediatric and Adolescent Health Care · doi:10.1016/j.cppeds.2009.01.001 · Cited by 413
“Manifesto” for Advancing the Control and Elimination of Neglected Tropical Diseases
Hotez, P. J., & Pecoul, B. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000718 · Cited by 138
“Antibiotics that destroy the parasite’s bacterial symbionts are also being explored for this purpose [58].”
BackgroundKlarmann-Schulz, U., Specht, S., Debrah, A. Y., Batsa, L., Ayisi-Boateng, N. K., Osei-Mensah, J., Mubarik, Y., Konadu, P., Ricchiuto, A., Fimmers, R., et al. (2017) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0005156 · Cited by 63
Self-citation
Metadata
- Authors
- Hoerauf, A.
- Venue
- Current Opinion in Infectious Diseases
- Published
- 2008-12
- Volume
- 21
- Issue
- 6
- Pages
- 673-681
- ISSN
- 0951-7375 (ISSN-L)
- OpenAlex
- W2114857398
- Cited by
- 211
- References
- 1
- FWCI
- 13.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.